Nakanishi T, Shimoaraiso M, Kubo T, Natori S
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
J Biol Chem. 1995 Apr 14;270(15):8991-5. doi: 10.1074/jbc.270.15.8991.
The yeast S-II null mutant is viable, but the mutation induces sensitivity to 6-azauracil. To examine whether the region needed for stimulation of RNA polymerase II and that for suppression of 6-azauracil sensitivity in the S-II molecule could be separated, we constructed various deletion mutants of S-II and expressed them in the null mutant using the GAL1 promoter to see if the mutant proteins suppressed 6-azauracil sensitivity. We also expressed these constructs in Escherichia coli, purified the mutant proteins to homogeneity, and examined if they stimulated RNA polymerase II. We found that a mutant protein lacking the first 147 amino acid residues suppressed 6-azauracil sensitivity but that removal of 2 additional residues completely abolished the suppression. A mutant protein lacking the first 141 residues had activity to stimulate RNA polymerase II, whereas removal of 10 additional residues completely abolished this activity. We also examined arrest-relief activity of these mutant proteins and found that there is a good correlation between RNA polymerase II-stimulating activity and arrest-relief activity. Therefore, at least the last 168 residues of S-II are sufficient for expressing these three activities.
酵母S-II基因缺失突变体是有活力的,但该突变会使其对6-氮尿嘧啶敏感。为了研究S-II分子中刺激RNA聚合酶II所需的区域与抑制6-氮尿嘧啶敏感性所需的区域是否可以分开,我们构建了各种S-II缺失突变体,并使用GAL1启动子在缺失突变体中表达它们,以观察突变蛋白是否能抑制6-氮尿嘧啶敏感性。我们还在大肠杆菌中表达了这些构建体,将突变蛋白纯化至同质,并检测它们是否能刺激RNA聚合酶II。我们发现,缺失前147个氨基酸残基的突变蛋白能抑制6-氮尿嘧啶敏感性,但再去除另外2个残基则完全消除了这种抑制作用。缺失前141个残基的突变蛋白具有刺激RNA聚合酶II的活性,而再去除另外10个残基则完全消除了这种活性。我们还检测了这些突变蛋白的解除阻滞活性,发现RNA聚合酶II刺激活性与解除阻滞活性之间存在良好的相关性。因此,S-II至少最后168个残基足以表达这三种活性。